HCV: Practical aspects: Decreasing barriers to care from initiation to re-treatment

Presenter:
Dr. Alnoor Ramji
Clinical Associate, Professor of Medicine
The University of British Columbia
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025